Andrew Steinmetz
Hematology & Oncology · Dayton, OHNPI 1063971901
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,358 of the $1,600 with a category attached, or 84.9%. It is spread thinly across 29 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,337, more than ten times the $82 reported in 2022. That places this record below the midpoint for hematology & oncology clinicians in OH, where the typical reported total is $2,354.
Across 64 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$177
- Merck$160
- Novartis$97
- Beone Medicines USA, Inc.$97
- AbbVie$84
- Pfizer$83
- plus $901 from 23 others
What the payments were for
- Food & beverage$1,35885%
- Education$24115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 4 | $177 |
| Merck | 6 | $160 |
| Novartis | 5 | $97 |
| Beone Medicines USA, Inc. | 3 | $97 |
| AbbVie | 3 | $84 |
| Pfizer | 4 | $83 |
| Seagen Inc. | 1 | $82 |
| AstraZeneca(2 entities) | 4 | $77 |
| Genentech USA, Inc. | 3 | $74 |
| Bayer | 3 | $66 |
| GSK | 3 | $62 |
| Stemline Therapeutics Inc. | 2 | $58 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Gilead(2 entities) | 2 | $45 |
| Caris MPI, Inc. | 2 | $37 |
| Springworks Therapeutics, Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Johnson & Johnson | 2 | $34 |
| Tersera Therapeutics LLC | 1 | $32 |
| Deciphera Pharmaceuticals Inc. | 2 | $30 |
| Taiho Oncology, Inc. | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $20 |
| Sanofi | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Syndax Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$1,600 in reported general payments places this provider in the 40th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Dayton
- Hillard LazarusCleveland$2M
- Kasra KaramlouSandusky$1.8M
- David WaterhouseCincinnati$1.3M
- Taral PatelColumbus$888K
- Tarek ChidiacColumbus$765K
- Saulius GirniusMontgomery$707K
- Ronald BukowskiCleveland$594K
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Alejandro CalvoKettering$463K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.